SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
46 hedge funds and large institutions have $25M invested in Sorrento Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-18
Holders Change %
-28.13%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
18
Reduced
7
Closed
29
Calls
$13K
Puts
$9K
Net Calls
+$4K
Net Calls Change
+$15K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.13M |
| 2 |
IP
Intellectus Partners
San Francisco,
California
|
+$980K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$779K |
| 4 |
Goldman Sachs
New York
|
+$502K |
| 5 |
ECM
Element Capital Management
New York
|
+$439K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.13M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$1.55M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$1.14M |
| 4 |
State Street
Boston,
Massachusetts
|
-$984K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$674K |
